Chinese experimental coronavirus vaccine safe in first stage trials
A Chinese experimental vaccine against COVID-19 developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences shows safe in a first-stage clinical trial. In Stage 1 of the clinical trial in 191 healthy participants between the ages of 18 and 59, vaccination with the institute’s experimental vaccine showed no serious side effects, the researchers said in their pre-publication.
The most common side effects reported by participants in the trial of this Chinese vaccine were mild pain, slight fatigue and redness, itching and swelling at the site of the vaccine. The candidate vaccine elicited an immune response.
“All the evidence from this trial suggests that this inactivated vaccine is safe and elicits an immune response and is encouraging in further studies of its effectiveness in the future,” the researchers said in their report.
China has vaccinated hundreds of thousands of workers in key sectors, as well as people in high-risk groups, with other experimental coronavirus vaccines, although their clinical trials have not yet been completed, raising concerns among experts about their safety. China has at least four experimental vaccines in the final stages of clinical trials.